NATURE’S SUNSHINE PRODUCTS, INC. Public Float
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Public Float of $211.30 million as of 2025-06-30, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-10
- 2025-06-30: Entity Public Float $211.30M.
- 2024-06-30: Entity Public Float $183.44M.
- 2023-06-30: Entity Public Float $178.82M.
- 2022-06-30: Entity Public Float $140.52M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $211.30M 10-K · filed 2026-03-10 |
| 2024-06-30 | $183.44M 10-K · filed 2025-03-11 |
| 2023-06-30 | $178.82M 10-K · filed 2024-03-12 |
| 2022-06-30 | $140.52M 10-K · filed 2023-03-16 |
| 2021-06-30 | $201.95M 10-K · filed 2022-03-08 |
| 2020-06-30 | $89.35M 10-K/A · filed 2021-07-09 |
| 2019-06-28 | $82.18M 10-K · filed 2020-03-11 |
| 2018-06-30 | $80.64M 10-K · filed 2019-03-08 |
| 2017-06-30 | $250.33M 10-K · filed 2018-03-16 |
| 2016-06-30 | $178.66M 10-K · filed 2017-03-14 |
| 2015-06-30 | $258.27M 10-K · filed 2016-03-14 |
| 2014-06-30 | $274.96M 10-K · filed 2015-03-13 |
| 2013-06-30 | $260.98M 10-K · filed 2014-03-17 |
| 2012-06-30 | $235.70M 10-K · filed 2013-03-07 |
| 2011-06-30 | $303.09M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |